Ablation of CTI-dependent flutter using different ablation technologies: acute and long-term outcome from the LEONARDO study.


Journal

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing
ISSN: 1572-8595
Titre abrégé: J Interv Card Electrophysiol
Pays: Netherlands
ID NLM: 9708966

Informations de publication

Date de publication:
Oct 2023
Historique:
received: 27 12 2022
accepted: 26 02 2023
medline: 4 10 2023
pubmed: 5 3 2023
entrez: 4 3 2023
Statut: ppublish

Résumé

A novel ablation catheter has been released to map and ablate the cavo-tricuspid isthmus (CTI) in patients with atrial flutter (AFL), improving ablation efficiency. We evaluated the acute and long-term outcome of CTI ablation aiming at bidirectional conduction block (BDB) in a prospective, multicenter cohort study enrolling 500 patients indicated for typical AFL ablation. Patients were grouped on the basis of the AFL ablation method (linear anatomical approach, Conv group n = 425, or maximum voltage guided, MVG group, n = 75) and ablation catheter (mini-electrodes technology, MiFi group, n = 254, or a standard 8-mm ablation catheter, BLZ group, n = 246). Complete BDB according to both validation criteria (sequential detailed activation mapping or mapping only the ablation site) was achieved in 443 patients (88.6%). The number of RF applications needed to achieve BDB was lower in the MiFi MVG group vs both the MiFi Conv group and the BLZ Conv group (3.2 ± 2 vs 5.2 ± 4 vs 9.3 ± 5, p < 0.0001 for all comparisons). Fluoroscopy time was similar among groups, whereas we observed a reduction in the procedure duration from the BLZ Conv group (61.9 ± 26min) to the MiFi MVG group (50.6 ± 17min, p = 0.048). During a mean follow-up of 548 ± 304 days, 32 (6.2%) patients suffered an AFL recurrence. No differences were found according to BDB achieved by both validation criteria. Ablation was highly effective in achieving acute CTI BDB and long-term arrhythmia freedom irrespective of the ablation strategy or the validation criteria for CTI chosen by the operator. The use of an ablation catheter equipped with mini-electrodes technology seems to improve ablation efficiency. Atrial Flutter Ablation in a Real World Population. (LEONARDO). gov Identifier: NCT02591875.

Sections du résumé

BACKGROUND BACKGROUND
A novel ablation catheter has been released to map and ablate the cavo-tricuspid isthmus (CTI) in patients with atrial flutter (AFL), improving ablation efficiency.
METHODS METHODS
We evaluated the acute and long-term outcome of CTI ablation aiming at bidirectional conduction block (BDB) in a prospective, multicenter cohort study enrolling 500 patients indicated for typical AFL ablation. Patients were grouped on the basis of the AFL ablation method (linear anatomical approach, Conv group n = 425, or maximum voltage guided, MVG group, n = 75) and ablation catheter (mini-electrodes technology, MiFi group, n = 254, or a standard 8-mm ablation catheter, BLZ group, n = 246).
RESULTS RESULTS
Complete BDB according to both validation criteria (sequential detailed activation mapping or mapping only the ablation site) was achieved in 443 patients (88.6%). The number of RF applications needed to achieve BDB was lower in the MiFi MVG group vs both the MiFi Conv group and the BLZ Conv group (3.2 ± 2 vs 5.2 ± 4 vs 9.3 ± 5, p < 0.0001 for all comparisons). Fluoroscopy time was similar among groups, whereas we observed a reduction in the procedure duration from the BLZ Conv group (61.9 ± 26min) to the MiFi MVG group (50.6 ± 17min, p = 0.048). During a mean follow-up of 548 ± 304 days, 32 (6.2%) patients suffered an AFL recurrence. No differences were found according to BDB achieved by both validation criteria.
CONCLUSIONS CONCLUSIONS
Ablation was highly effective in achieving acute CTI BDB and long-term arrhythmia freedom irrespective of the ablation strategy or the validation criteria for CTI chosen by the operator. The use of an ablation catheter equipped with mini-electrodes technology seems to improve ablation efficiency.
CLINICAL TRIAL REGISTRATION BACKGROUND
Atrial Flutter Ablation in a Real World Population. (LEONARDO).
CLINICALTRIALS RESULTS
gov Identifier: NCT02591875.

Identifiants

pubmed: 36869990
doi: 10.1007/s10840-023-01519-7
pii: 10.1007/s10840-023-01519-7
doi:

Substances chimiques

bis(diazo)benzidine 5957-03-9

Banques de données

ClinicalTrials.gov
['NCT02591875']

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1749-1757

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Katritsis DG, Boriani G, Cosio FG, Hindricks G, Jaïs P, Josephson ME, et al. European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardiaca y Electrofisiologia (SOLAECE). Europace. 2017;19:465–511. https://doi.org/10.1093/europace/euw301 .
doi: 10.1093/europace/euw301 pubmed: 27856540
Shah D, Haissaguerre M, Takahashi A, Jais P, Hocini M, Clementy J. Differential pacing for distinguishing block from persistent conduction through an ablation line. Circulation. 2000;102:1517–22.
doi: 10.1161/01.CIR.102.13.1517 pubmed: 11004142
Patel NJ, Deshmukh A, Pau D, Goyal V, Patel SV, Patel N, et al. Contemporary utilization and safety outcomes of catheter ablation of atrial flutter in the United States: analysis of 89,638 procedures. Heart Rhythm. 2016;13:1317–25.
doi: 10.1016/j.hrthm.2016.02.005 pubmed: 26861515
Redfearn DP, Skanes AC, Gula LJ, Krahn AD, Yee R, Klein GJ. Cavotricuspid isthmus conduction is dependent on underlying anatomic bundle architecture: observations using a maximum voltageguided ablation technique. J Cardiovasc Electrophysiol. 2006;17:832–8.
doi: 10.1111/j.1540-8167.2006.00512.x pubmed: 16903961
Shah DC, Haissaguerre M, Jais P, Fischer B, Takahashi A, Hocini M, et al. Simplified electrophysiologically directed catheter ablation of recurrent common atrial flutter. Circulation. 1997;96:2505–8.
doi: 10.1161/01.CIR.96.8.2505 pubmed: 9355885
Tzeis S, Pastromas S, Andrikopoulos G. Ablation of cavotricuspid isthmus-dependent flutter using a mini-electrode-equipped 8-mm ablation catheter: case series. Hellenic Journal of Cardiology. 2016;57:53–8.
doi: 10.1016/S1109-9666(16)30021-5 pubmed: 26856204
Cosio FG, Arribas F, Lopez-Gil M, Gonzalez HD. Atrial flutter mapping and ablation II. Radiofrequency ablation of atrial flutter circuits. Pacing Clin Electrophysiol. 1996;19:965–75.
doi: 10.1111/j.1540-8159.1996.tb03394.x pubmed: 8774828
Da Costa A, Thevenin J, Roche F, Romeyer-Bouchard C, Abdellaoui L, Messier M, et al. Results from the Loire-Ardeche-Drome-Isere-Puy-de-Dome (LADIP) trial on atrial flutter, a multicentric prospective randomized study comparing amiodarone and radiofrequency ablation after the first episode of symptomatic atrial flutter. Circulation. 2006;114:1676–81.
doi: 10.1161/CIRCULATIONAHA.106.638395 pubmed: 17030680
Viola G, Stabile G, Bandino S, Rossi L, Marrazzo N, Pecora D, et al. Safety, efficacy, and reproducibility of cavotricuspid isthmus ablation guided by the ablation index: acute results of the FLAI study Europace. 2021;23:264–70. https://doi.org/10.1093/europace/euaa215 .
doi: 10.1093/europace/euaa215 pubmed: 33212484
Kakehashi S, Miyazaki S, Hasegawa K, Nodera M, Mukai M, Aoyama D, et al. Safety and durability of cavo-tricuspid isthmus linear ablation in the current era: single-center 9-year experience from 1078 procedures. J Cardiovasc Electrophysiol. 2022;33:40–5. https://doi.org/10.1111/jce.15281 Epub 2021 Oct 27.
doi: 10.1111/jce.15281 pubmed: 34676946
Schillaci V, Strisciuglio T, Stabile G, Salito A, Arestia A, Agresta A, et al. Cavotricuspid isthmus ablation by means of very high power, short-duration, temperature-controlled lesions. J Interv Card Electrophysiol. 2022;65(1):97–102. https://doi.org/10.1007/s10840-022-01197-x .
doi: 10.1007/s10840-022-01197-x pubmed: 35378611
Mechulan A, Gula LJ, Klein GJ, Leong-Sit P, Obeyesekere M, Krahn AD, et al. Further evidence for the "muscle bundle" hypothesis of cavotricuspid isthmus conduction: physiological proof, with clinical implications for ablation. J Cardiovasc Electrophysiol. 2013;24:47–52.
doi: 10.1111/j.1540-8167.2012.02415.x pubmed: 22909255
Subbiah RN, Gula LJ, Krahn AD, Posan E, Yee R, Klein GJ, et al. Rapid ablation for atrial flutter by targeting maximum voltage-factors associated with short ablation times. J Cardiovasc Electrophysiol. 2007;18:612–6.
doi: 10.1111/j.1540-8167.2007.00804.x pubmed: 17403079
Gula LJ, Redfearn DP, Veenhuyzen GD, Krahn AD, Yee R, Klein GJ, et al. Reduction in atrial flutter ablation time by targeting maximum voltage: results of a prospective randomized clinical trial. J Cardiovasc Electrophysiol. 2009;20:1108–12.
doi: 10.1111/j.1540-8167.2009.01511.x pubmed: 19549033
Arenal A, Almendral J, Alday JM, illacastín J, Ormaetxe JM, Sande JL et al. Rate-dependent conduction block of the crista terminalis in patients with typical atrial flutter: influence on evaluation of cavotricuspid isthmus conduction block. Circulation 1999;99:2771–2778.
Tada H, Oral H, Sticherling C, Chough SP, Baker RL, Wasmer K, et al. Double potentials along the ablation line as a guide to radiofrequency ablation of typical atrial flutter. J Am Coll Cardiol. 2001;38:750–5.
doi: 10.1016/S0735-1097(01)01425-5 pubmed: 11527628
Anselme F, Savouré A, Cribier A, Saoudi N. Catheter ablation of typical atrial flutter: a randomized comparison of 2 methods for determining complete bidirectional isthmus block. Circulation. 2001;103:1434–9.
doi: 10.1161/01.CIR.103.10.1434 pubmed: 11245649
Bińkowski BJ, Kucejko T, Łagodziński A, Lubiński A. How to avoid unnecessary RF applications in cavo-tricuspid isthmus: common atrial flutter ablation using 8-mm-tip mini-electrode-equipped catheter. Interv Card Electrophysiol. 2021;60:109–14.
doi: 10.1007/s10840-020-00715-z
Takagi T, Miyazaki S, Niida T, Kajiyama T, Watanabe T, Kusa S, et al. Prospective evaluation of a novel catheter equipped with mini electrodes on a 10-mm tip for cavotricuspid isthmus ablation - the efficacy of a mini electrode guided ablation. Int J Cardiol. 2017;240:203–7.
doi: 10.1016/j.ijcard.2017.03.128 pubmed: 28372867
Rowe MK, Claughton A, Davis J, Yee L, Kaye GC, Dauber K, et al. Ablation of typical atrial flutter using mini electrode measurements for maximum voltage-guided ablation: a randomized, controlled trial. J Arrhythm. 2021;38:106–14.
doi: 10.1002/joa3.12665 pubmed: 35222756 pmcid: 8851573
Somani R, Ng GA, Hobson NA, Redfearn DP, Caldwell JC. A comparison of the efficacy of voltage-directed cavotricuspid isthmus ablation using mini versus conventional electrodes. J Innnov Card Rhythm Manag. 2018;9:3198–203.
doi: 10.19102/icrm.2018.090603

Auteurs

Giampiero Maglia (G)

Cardiology - Coronary Care Unit, Electrophysiology and Cardiac Pacing, Pugliese - Ciaccio Hospital, Via Pio X, 88100, Catanzaro, Italy. pmaglia@libero.it.

Francesco Pentimalli (F)

S.S. di Elettrofisiologia Cardiaca, S.C. di Cardiologia, Ospedale S. Paolo, Savona, Italy.

Roberto Verlato (R)

ULSS 6 Euganea, Ospedale di Camposampiero-Cittadella, Cittadella, Padova, Italy.
Cardiology Unit, Civil Hospital, Camposampiero, Padova, Italy.

Francesco Solimene (F)

Clinica Montevergine, Mercogliano, Avellino, Italy.

Maurizio Malacrida (M)

Boston Scientific, Milan, Italy.

Vittorio Aspromonte (V)

Cardiology - Coronary Care Unit, Electrophysiology and Cardiac Pacing, Pugliese - Ciaccio Hospital, Via Pio X, 88100, Catanzaro, Italy.

Luca Bacino (L)

S.S. di Elettrofisiologia Cardiaca, S.C. di Cardiologia, Ospedale S. Paolo, Savona, Italy.

Pietro Turrini (P)

Cardiology Unit, Civil Hospital, Camposampiero, Padova, Italy.

Tommaso Infusino (T)

S. Anna Hospital, Catanzaro, Italy.

Carmelo La Greca (C)

Fondazione Poliambulanza, Brescia, Italy.

Giovanni Battista Perego (GB)

Istituto Auxologico Italiano IRCCS, Ospedale San Luca, Milan, Italy.

Andrea Antonio Papa (AA)

Cardiology Unit, Department of Cardiology, Monaldi - Hospital, Naples, Italy.

Ermenegildo De Ruvo (E)

Department of Cardiology, Policlinico Casilino of Rome, Rome, Italy.

Gianluca Zingarini (G)

Santa Maria della Misericordia Hospital, Perugia, Italy.

Chiara Devecchi (C)

Division of Cardiology, Sant'Andrea Hospital, Vercelli, Italy.

Marco Scaglione (M)

Cardiology Division, Ospedale Cardinal Massaia, Asti, Italy.

Corrado Tomasi (C)

U.O.C. Cardiologia di Ravenna, Faenza e Lugo, Ospedale "S. Maria delle Croci", Ravenna, Italy.

Salvatore Pirrotta (S)

Cardiology - Coronary Care Unit, Electrophysiology and Cardiac Pacing, Pugliese - Ciaccio Hospital, Via Pio X, 88100, Catanzaro, Italy.

Giuseppe Stabile (G)

Mediterranea Cardiocentro, Naples, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH